Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 44 No. 1 › Euprolactinemic Gynecomastia and...
COMPLICATED CASE HISTORIES

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination

Pratheesh P.J., Samir Kumar Praharaj, Ashish Srivastava
Psychopharmacology Bulletin 44(1) :70-73 , 2011/02/15

Abstract

Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynnecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects. We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.

Keywords

Fluvoxamine, Galactorrhea, Gynecomastia, risperidone

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Pratheesh P.J., Samir Kumar Praharaj, Ashish Srivastava. Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination. Psychopharmacology Bulletin. 2011/02/15; 44(1):70-73.